Arabic Arabic English English French French German German
dark

Ligand Pharmaceuticals Appoints Dr. Jennifer Cochran to its Board of Directors

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (“Ligand” or “the Company”) announces the appointment of Jennifer Cochran, Ph.D. to the Company’s Board of Directors. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Pharma Faces a Turn in the Tides as Biden Demands Health Care Reforms

Next Post

COVID Vaccine’s 2nd Dose Boosts Body Immunity, MOH Says

Related Posts
Total
0
Share